Cardinal Health (CAH) 10-K Summaries & Annual Filing History
Review Cardinal Health, Inc. (CAH) 10-K filings from 2023 through the latest annual report, including business, financial performance, risks, and liquidity.
Key takeaway
Year ended Jun 30, 2025 · FY2025 10-K
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. The company reported a slight decline in annual revenue compared to the prior year, with operating income and net income both remaining positive.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$222.6B
Revenue reported for the fiscal year.
Operating income
$2.3B
Income from operations reported for the year.
Net income
$1.6B
Net income reported for the year.
Operating cash flow
$2.4B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $57.4B | +5.1% |
| Mar 31, 2024 | $54.9B | -4.5% |
| Jun 30, 2024 | $226.8B | +313.4% |
| Jun 30, 2025 | $222.6B | -1.9% |
Business overview
The company operates primarily in pharmaceutical distribution and medical product supply. It serves customers including hospitals, pharmacies, and healthcare providers across the United States. The filing does not specify detailed business segments beyond these general activities.
Financial performance
Revenue for the fiscal year was reported as over two hundred billion dollars, a decrease from the prior year's level. Operating income was over two billion dollars and net income was over one billion dollars. Cash from operations was over two billion dollars, reflecting ongoing operating cash generation despite the revenue decline.
Material risks
The filing references risk factors related to cybersecurity, legal proceedings including opioid litigation, and market conditions for common equity. No specific quantification of these risks is provided in the supplied context.
Liquidity and capital
The company states it believes it has adequate capital resources to fund operations and expected cash needs, based on available capital and projected operating cash flow. During the period, cash was used for acquisitions, share repurchases, debt repayment, capital expenditures, and dividends, partly funded by new debt issuance and a term loan.
What to watch
Investors should monitor the company's revenue trend, as it declined compared to the prior period, to see if it stabilizes or continues to decrease.